Lyell Immunopharma Appoints Charlie Newton as Chief Financial Officer
Press release from PR Newswire SAN FRANCISCO, Feb. 9, 2021 /PRNewswire/ — Lyell Immunopharma (“Lyell”), an immuno-oncology company dedicated to the mastery of T cells to cure solid tumors, today announced the appointment of Charlie Newton as Chief Financial Officer. “Charlie is a wonderful addition to our leadership team and we’re excited to have him … Continued
